

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.44238947 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.44238947 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.13230395 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.13230395 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.61760958 |
| 6 | regulation of skeletal muscle contraction (GO:0014819) | 6.49063576 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.11638998 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.88047579 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.88047579 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.88047579 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.73872119 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.69315204 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.68933114 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.55770876 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.48636544 |
| 16 | cysteine metabolic process (GO:0006534) | 5.40479674 |
| 17 | sulfur amino acid catabolic process (GO:0000098) | 5.34806019 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.34203201 |
| 19 | urea cycle (GO:0000050) | 5.31592575 |
| 20 | urea metabolic process (GO:0019627) | 5.31592575 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.22458949 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.11975493 |
| 23 | protein carboxylation (GO:0018214) | 5.11975493 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.04147372 |
| 25 | complement activation, alternative pathway (GO:0006957) | 5.01300001 |
| 26 | serine family amino acid catabolic process (GO:0009071) | 4.99354777 |
| 27 | regulation of protein activation cascade (GO:2000257) | 4.93400359 |
| 28 | homocysteine metabolic process (GO:0050667) | 4.91037764 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.90793821 |
| 30 | bile acid metabolic process (GO:0008206) | 4.89963393 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 4.89620008 |
| 32 | negative regulation of cell aging (GO:0090344) | 4.83321275 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 4.80321954 |
| 34 | transepithelial transport (GO:0070633) | 4.75784117 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 4.75504064 |
| 36 | reverse cholesterol transport (GO:0043691) | 4.73382522 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 4.73251199 |
| 38 | lysine metabolic process (GO:0006553) | 4.71963071 |
| 39 | lysine catabolic process (GO:0006554) | 4.71963071 |
| 40 | DNA strand renaturation (GO:0000733) | 4.67889182 |
| 41 | detection of light stimulus involved in sensory perception (GO:0050962) | 4.66028945 |
| 42 | detection of light stimulus involved in visual perception (GO:0050908) | 4.66028945 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.63762805 |
| 44 | regulation of complement activation (GO:0030449) | 4.61960836 |
| 45 | alpha-amino acid catabolic process (GO:1901606) | 4.57467582 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.57301615 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 4.57301615 |
| 48 | macromolecular complex remodeling (GO:0034367) | 4.57301615 |
| 49 | cellular response to ATP (GO:0071318) | 4.56959094 |
| 50 | amino-acid betaine metabolic process (GO:0006577) | 4.56740737 |
| 51 | cellular ketone body metabolic process (GO:0046950) | 4.53767186 |
| 52 | mitotic cell cycle arrest (GO:0071850) | 4.53022241 |
| 53 | regulation of synapse structural plasticity (GO:0051823) | 4.49723870 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.45312046 |
| 55 | triglyceride homeostasis (GO:0070328) | 4.45312046 |
| 56 | phospholipid efflux (GO:0033700) | 4.44959245 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 4.43543383 |
| 58 | negative regulation of sterol transport (GO:0032372) | 4.43543383 |
| 59 | cellular amino acid catabolic process (GO:0009063) | 4.25272643 |
| 60 | plasma lipoprotein particle clearance (GO:0034381) | 4.22660660 |
| 61 | bile acid and bile salt transport (GO:0015721) | 4.19480197 |
| 62 | indolalkylamine metabolic process (GO:0006586) | 4.18556252 |
| 63 | GDP-mannose metabolic process (GO:0019673) | 4.16536383 |
| 64 | coenzyme catabolic process (GO:0009109) | 4.16276926 |
| 65 | glycine metabolic process (GO:0006544) | 4.15028873 |
| 66 | cellular glucuronidation (GO:0052695) | 4.14221278 |
| 67 | glutamate metabolic process (GO:0006536) | 4.13063568 |
| 68 | benzene-containing compound metabolic process (GO:0042537) | 4.11839644 |
| 69 | serine family amino acid metabolic process (GO:0009069) | 4.10451211 |
| 70 | drug catabolic process (GO:0042737) | 4.10002585 |
| 71 | amine catabolic process (GO:0009310) | 4.08785933 |
| 72 | cellular biogenic amine catabolic process (GO:0042402) | 4.08785933 |
| 73 | cellular modified amino acid catabolic process (GO:0042219) | 4.06351403 |
| 74 | respiratory chain complex IV assembly (GO:0008535) | 4.04387104 |
| 75 | imidazole-containing compound metabolic process (GO:0052803) | 4.03466059 |
| 76 | cholesterol efflux (GO:0033344) | 4.03138847 |
| 77 | ethanol oxidation (GO:0006069) | 4.03131498 |
| 78 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 3.97866886 |
| 79 | estrogen biosynthetic process (GO:0006703) | 3.95108316 |
| 80 | ketone body metabolic process (GO:1902224) | 3.92300924 |
| 81 | serine family amino acid biosynthetic process (GO:0009070) | 3.90186792 |
| 82 | short-chain fatty acid metabolic process (GO:0046459) | 3.89447320 |
| 83 | plasma lipoprotein particle assembly (GO:0034377) | 3.86368674 |
| 84 | arginine metabolic process (GO:0006525) | 3.84619359 |
| 85 | aldehyde catabolic process (GO:0046185) | 3.84110986 |
| 86 | low-density lipoprotein particle remodeling (GO:0034374) | 3.83860477 |
| 87 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.83178789 |
| 88 | behavioral response to nicotine (GO:0035095) | 3.80080169 |
| 89 | organic acid catabolic process (GO:0016054) | 3.78727596 |
| 90 | carboxylic acid catabolic process (GO:0046395) | 3.78727596 |
| 91 | fibrinolysis (GO:0042730) | 3.76094393 |
| 92 | drug transmembrane transport (GO:0006855) | 3.73849006 |
| 93 | cytochrome complex assembly (GO:0017004) | 3.71083136 |
| 94 | uronic acid metabolic process (GO:0006063) | 3.70216253 |
| 95 | glucuronate metabolic process (GO:0019585) | 3.70216253 |
| 96 | response to nitrosative stress (GO:0051409) | 3.67654423 |
| 97 | phospholipid homeostasis (GO:0055091) | 3.67548449 |
| 98 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.67477936 |
| 99 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.67477936 |
| 100 | positive regulation of lipid catabolic process (GO:0050996) | 3.66909808 |
| 101 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.66594060 |
| 102 | acetyl-CoA metabolic process (GO:0006084) | 3.65615520 |
| 103 | regulation of bile acid biosynthetic process (GO:0070857) | 3.63373373 |
| 104 | negative regulation of lipase activity (GO:0060192) | 3.63292980 |
| 105 | flavonoid metabolic process (GO:0009812) | 3.62507968 |
| 106 | cholesterol homeostasis (GO:0042632) | 3.62397466 |
| 107 | cofactor catabolic process (GO:0051187) | 3.58816977 |
| 108 | regulation of cholesterol homeostasis (GO:2000188) | 3.58774593 |
| 109 | urate metabolic process (GO:0046415) | 3.57847824 |
| 110 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.57805748 |
| 111 | sterol homeostasis (GO:0055092) | 3.56888542 |
| 112 | blood coagulation, intrinsic pathway (GO:0007597) | 3.56685236 |
| 113 | monocarboxylic acid catabolic process (GO:0072329) | 3.56336413 |
| 114 | fatty acid beta-oxidation (GO:0006635) | 3.56238364 |
| 115 | fatty acid oxidation (GO:0019395) | 3.54091945 |
| 116 | drug metabolic process (GO:0017144) | 3.54066459 |
| 117 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.35670265 |
| 118 | protein complex biogenesis (GO:0070271) | 3.28770566 |
| 119 | peptidyl-glutamic acid modification (GO:0018200) | 3.23452455 |
| 120 | heme transport (GO:0015886) | 3.23095735 |
| 121 | axoneme assembly (GO:0035082) | 3.07725975 |
| 122 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.07367047 |
| 123 | lens fiber cell differentiation (GO:0070306) | 3.01296128 |
| 124 | mannosylation (GO:0097502) | 2.98465972 |
| 125 | ATP synthesis coupled proton transport (GO:0015986) | 2.97815622 |
| 126 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.97815622 |
| 127 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.94522630 |
| 128 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.93859537 |
| 129 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.92641557 |
| 130 | NADH dehydrogenase complex assembly (GO:0010257) | 2.92641557 |
| 131 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.92641557 |
| 132 | iron coordination entity transport (GO:1901678) | 2.89412949 |
| 133 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.87484873 |
| 134 | response to gravity (GO:0009629) | 2.87095012 |
| 135 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.85810777 |
| 136 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.85810777 |
| 137 | nephron tubule morphogenesis (GO:0072078) | 2.85651167 |
| 138 | nephron epithelium morphogenesis (GO:0072088) | 2.85651167 |
| 139 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.75235296 |
| 140 | rRNA modification (GO:0000154) | 2.75131162 |
| 141 | positive regulation of heat generation (GO:0031652) | 2.74216970 |
| 142 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.73717842 |
| 143 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.70768951 |
| 144 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.69495755 |
| 145 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.68379160 |
| 146 | rRNA methylation (GO:0031167) | 2.67489323 |
| 147 | cardiolipin metabolic process (GO:0032048) | 2.63375377 |
| 148 | trivalent inorganic anion homeostasis (GO:0072506) | 2.63100194 |
| 149 | phosphate ion homeostasis (GO:0055062) | 2.63100194 |
| 150 | meiotic chromosome segregation (GO:0045132) | 2.62809988 |
| 151 | nucleoside transmembrane transport (GO:1901642) | 2.62595368 |
| 152 | epithelial cilium movement (GO:0003351) | 2.59019720 |
| 153 | neuromuscular synaptic transmission (GO:0007274) | 2.58937852 |
| 154 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.58556773 |
| 155 | base-excision repair, AP site formation (GO:0006285) | 2.57412256 |
| 156 | nucleotide transmembrane transport (GO:1901679) | 2.56961932 |
| 157 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.56221620 |
| 158 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.54632429 |
| 159 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.53285043 |
| 160 | GPI anchor biosynthetic process (GO:0006506) | 2.53039239 |
| 161 | positive regulation of TOR signaling (GO:0032008) | 2.50679089 |
| 162 | GPI anchor metabolic process (GO:0006505) | 2.49053988 |
| 163 | sulfation (GO:0051923) | 2.47697785 |
| 164 | urinary tract smooth muscle contraction (GO:0014848) | 2.45589736 |
| 165 | peptidyl-histidine modification (GO:0018202) | 2.45078040 |
| 166 | peristalsis (GO:0030432) | 2.41914975 |
| 167 | regulation of heat generation (GO:0031650) | 2.41826648 |
| 168 | glutathione biosynthetic process (GO:0006750) | 2.41768667 |
| 169 | intestinal cholesterol absorption (GO:0030299) | 2.40738946 |
| 170 | C-terminal protein lipidation (GO:0006501) | 2.40493708 |
| 171 | L-methionine biosynthetic process (GO:0071265) | 2.39565412 |
| 172 | amino acid salvage (GO:0043102) | 2.39565412 |
| 173 | L-methionine salvage (GO:0071267) | 2.39565412 |
| 174 | response to ATP (GO:0033198) | 2.38408204 |
| 175 | pseudouridine synthesis (GO:0001522) | 2.38054292 |
| 176 | protein import into peroxisome matrix (GO:0016558) | 2.37425278 |
| 177 | vitamin biosynthetic process (GO:0009110) | 2.37180608 |
| 178 | photoreceptor cell development (GO:0042461) | 2.36631765 |
| 179 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.35878630 |
| 180 | positive regulation of protein kinase C signaling (GO:0090037) | 2.35637145 |
| 181 | renal absorption (GO:0070293) | 2.35600319 |
| 182 | phosphatidylcholine biosynthetic process (GO:0006656) | 2.34969220 |
| 183 | electron transport chain (GO:0022900) | 2.34747871 |
| 184 | branched-chain amino acid catabolic process (GO:0009083) | 2.33899062 |
| 185 | NAD biosynthetic process (GO:0009435) | 2.31166341 |
| 186 | phenol-containing compound catabolic process (GO:0019336) | 2.30383983 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.11936932 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.94339769 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.63121169 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.30492082 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.14058721 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.05982221 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.86512932 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.98956467 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.74601671 |
| 10 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.91715983 |
| 11 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.36580766 |
| 12 | P68_20966046_ChIP-Seq_HELA_Human | 2.28287796 |
| 13 | E2F1_20622854_ChIP-Seq_HELA_Human | 2.22608938 |
| 14 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.20690180 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.15170349 |
| 16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.08877855 |
| 17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.08697582 |
| 18 | CTCF_27219007_Chip-Seq_Bcells_Human | 2.02725053 |
| 19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.02154573 |
| 20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.01737450 |
| 21 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.00804603 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4964292 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.99110774 |
| 24 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.98540437 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.91485347 |
| 26 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.89690741 |
| 27 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.83889486 |
| 28 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83130662 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.81489267 |
| 30 | ERA_21632823_ChIP-Seq_H3396_Human | 1.80242992 |
| 31 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.79051429 |
| 32 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.76828426 |
| 33 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.76810746 |
| 34 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.76162484 |
| 35 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.70738820 |
| 36 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.68882373 |
| 37 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.67963306 |
| 38 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.66663621 |
| 39 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.64686939 |
| 40 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.62785582 |
| 41 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.62681588 |
| 42 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.58781108 |
| 43 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57531507 |
| 44 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.56883669 |
| 45 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.55097613 |
| 46 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.52781566 |
| 47 | EWS_26573619_Chip-Seq_HEK293_Human | 1.50608620 |
| 48 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.50173978 |
| 49 | VDR_22108803_ChIP-Seq_LS180_Human | 1.48025648 |
| 50 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.44980711 |
| 51 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.43437139 |
| 52 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.41930792 |
| 53 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.38219545 |
| 54 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37305448 |
| 55 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.33888328 |
| 56 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.33368497 |
| 57 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.33089047 |
| 58 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30797547 |
| 59 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.28197888 |
| 60 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.25770497 |
| 61 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.24722789 |
| 62 | SA1_27219007_Chip-Seq_Bcells_Human | 1.24473061 |
| 63 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.24031011 |
| 64 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.23807101 |
| 65 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.23349849 |
| 66 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.23229897 |
| 67 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.20737425 |
| 68 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20486875 |
| 69 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.18464344 |
| 70 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.17022077 |
| 71 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.15760811 |
| 72 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.15432590 |
| 73 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.14998221 |
| 74 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14602696 |
| 75 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.14560280 |
| 76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.14396855 |
| 77 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.13329514 |
| 78 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.11812573 |
| 79 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.10881468 |
| 80 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.10216307 |
| 81 | FUS_26573619_Chip-Seq_HEK293_Human | 1.09155176 |
| 82 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08987871 |
| 83 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.08956900 |
| 84 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.08658550 |
| 85 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.08382420 |
| 86 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.08134905 |
| 87 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05898083 |
| 88 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05777428 |
| 89 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.04737644 |
| 90 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.04448937 |
| 91 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.02342846 |
| 92 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02132773 |
| 93 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.01595010 |
| 94 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.00671291 |
| 95 | NCOR_22424771_ChIP-Seq_293T_Human | 0.99138007 |
| 96 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.99101539 |
| 97 | P300_27268052_Chip-Seq_Bcells_Human | 0.98077976 |
| 98 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96915577 |
| 99 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96592248 |
| 100 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.96313831 |
| 101 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.94808566 |
| 102 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.94155345 |
| 103 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92988218 |
| 104 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.92521956 |
| 105 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.92500307 |
| 106 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.92169902 |
| 107 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.91848127 |
| 108 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.88977904 |
| 109 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.88789437 |
| 110 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86144125 |
| 111 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.85405338 |
| 112 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.84630660 |
| 113 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82281392 |
| 114 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81793520 |
| 115 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80630937 |
| 116 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.76716004 |
| 117 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75595319 |
| 118 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73426113 |
| 119 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72991805 |
| 120 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72872426 |
| 121 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72872426 |
| 122 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72324787 |
| 123 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71731973 |
| 124 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71516736 |
| 125 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.69319937 |
| 126 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.68830352 |
| 127 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.68654134 |
| 128 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.68327507 |
| 129 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.68182737 |
| 130 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.68131407 |
| 131 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.67515506 |
| 132 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.65939727 |
| 133 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.60132697 |
| 134 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.58693669 |
| 135 | AR_20517297_ChIP-Seq_VCAP_Human | 0.58691851 |
| 136 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58217855 |
| 137 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.57240091 |
| 138 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.57087377 |
| 139 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.56631513 |
| 140 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.56441859 |
| 141 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56098065 |
| 142 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.55653417 |
| 143 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53750448 |
| 144 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.53397336 |
| 145 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.51512935 |
| 146 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.51253942 |
| 147 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.50936995 |
| 148 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50220970 |
| 149 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.50162720 |
| 150 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.50145474 |
| 151 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49790964 |
| 152 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49412035 |
| 153 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.49253803 |
| 154 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.49049820 |
| 155 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.48977618 |
| 156 | GATA1_19941826_ChIP-Seq_K562_Human | 0.48371451 |
| 157 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.47121992 |
| 158 | GATA2_19941826_ChIP-Seq_K562_Human | 0.47081365 |
| 159 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.46896896 |
| 160 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.46577698 |
| 161 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.46551874 |
| 162 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.46271810 |
| 163 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45955410 |
| 164 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.45763577 |
| 165 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.45184957 |
| 166 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.44549450 |
| 167 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43189518 |
| 168 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.43030035 |
| 169 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.42450696 |
| 170 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.42080515 |
| 171 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41366391 |
| 172 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.39439524 |
| 173 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.39406449 |
| 174 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.39097372 |
| 175 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.38547259 |
| 176 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.37540283 |
| 177 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.37465914 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.16351952 |
| 2 | MP0005360_urolithiasis | 7.48085451 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.23665670 |
| 4 | MP0005365_abnormal_bile_salt | 6.09112875 |
| 5 | MP0005171_absent_coat_pigmentation | 4.92008646 |
| 6 | * MP0008875_abnormal_xenobiotic_pharmacok | 4.86339663 |
| 7 | MP0003136_yellow_coat_color | 4.27002735 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 4.01246977 |
| 9 | MP0003252_abnormal_bile_duct | 3.91467123 |
| 10 | MP0001986_abnormal_taste_sensitivity | 3.74194056 |
| 11 | MP0005174_abnormal_tail_pigmentation | 3.61634344 |
| 12 | MP0010329_abnormal_lipoprotein_level | 3.50250884 |
| 13 | MP0005423_abnormal_somatic_nervous | 3.29614254 |
| 14 | MP0005083_abnormal_biliary_tract | 3.12447601 |
| 15 | MP0009840_abnormal_foam_cell | 3.10499154 |
| 16 | MP0003195_calcinosis | 2.94589748 |
| 17 | MP0005332_abnormal_amino_acid | 2.90316502 |
| 18 | MP0001968_abnormal_touch/_nociception | 2.88326902 |
| 19 | MP0002736_abnormal_nociception_after | 2.83472541 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.72074600 |
| 21 | MP0002638_abnormal_pupillary_reflex | 2.63909211 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 2.33017681 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.27878749 |
| 24 | MP0005551_abnormal_eye_electrophysiolog | 2.26016667 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 2.22273246 |
| 26 | MP0002160_abnormal_reproductive_system | 2.12001585 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 2.11746465 |
| 28 | MP0000751_myopathy | 2.11550259 |
| 29 | MP0000609_abnormal_liver_physiology | 2.07757388 |
| 30 | MP0003868_abnormal_feces_composition | 1.89281313 |
| 31 | MP0004147_increased_porphyrin_level | 1.84362389 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.81316712 |
| 33 | MP0001502_abnormal_circadian_rhythm | 1.78341126 |
| 34 | MP0001764_abnormal_homeostasis | 1.68604268 |
| 35 | MP0000538_abnormal_urinary_bladder | 1.65071151 |
| 36 | MP0005253_abnormal_eye_physiology | 1.60662932 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57871148 |
| 38 | MP0005410_abnormal_fertilization | 1.56225931 |
| 39 | MP0003646_muscle_fatigue | 1.55487290 |
| 40 | MP0005330_cardiomyopathy | 1.51505342 |
| 41 | MP0002909_abnormal_adrenal_gland | 1.50552019 |
| 42 | MP0001188_hyperpigmentation | 1.48682754 |
| 43 | MP0003011_delayed_dark_adaptation | 1.48088725 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.48073428 |
| 45 | MP0009697_abnormal_copulation | 1.44948896 |
| 46 | MP0004215_abnormal_myocardial_fiber | 1.43996629 |
| 47 | MP0005451_abnormal_body_composition | 1.38415753 |
| 48 | MP0000013_abnormal_adipose_tissue | 1.38235520 |
| 49 | MP0004145_abnormal_muscle_electrophysio | 1.36039485 |
| 50 | MP0003186_abnormal_redox_activity | 1.35574671 |
| 51 | MP0004133_heterotaxia | 1.34647632 |
| 52 | MP0003137_abnormal_impulse_conducting | 1.34054983 |
| 53 | MP0001905_abnormal_dopamine_level | 1.32065952 |
| 54 | MP0002938_white_spotting | 1.27212270 |
| 55 | MP0002735_abnormal_chemical_nociception | 1.23786993 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.18671017 |
| 57 | MP0000750_abnormal_muscle_regeneration | 1.16713597 |
| 58 | MP0001664_abnormal_digestion | 1.12264957 |
| 59 | MP0000598_abnormal_liver_morphology | 1.11484677 |
| 60 | MP0005377_hearing/vestibular/ear_phenot | 1.10732535 |
| 61 | MP0003878_abnormal_ear_physiology | 1.10732535 |
| 62 | MP0005636_abnormal_mineral_homeostasis | 1.08987759 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.07267578 |
| 64 | MP0002272_abnormal_nervous_system | 1.04677225 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 1.04480506 |
| 66 | MP0005647_abnormal_sex_gland | 1.03925367 |
| 67 | MP0002254_reproductive_system_inflammat | 1.01290626 |
| 68 | MP0009764_decreased_sensitivity_to | 1.01135190 |
| 69 | MP0001970_abnormal_pain_threshold | 1.00349488 |
| 70 | MP0010368_abnormal_lymphatic_system | 0.99393735 |
| 71 | MP0001324_abnormal_eye_pigmentation | 0.96693255 |
| 72 | MP0001984_abnormal_olfaction | 0.96652901 |
| 73 | MP0005389_reproductive_system_phenotype | 0.95716646 |
| 74 | MP0005646_abnormal_pituitary_gland | 0.95015421 |
| 75 | MP0009763_increased_sensitivity_to | 0.94524055 |
| 76 | MP0005670_abnormal_white_adipose | 0.93697988 |
| 77 | MP0000604_amyloidosis | 0.93445785 |
| 78 | MP0005220_abnormal_exocrine_pancreas | 0.92674774 |
| 79 | MP0009046_muscle_twitch | 0.91590129 |
| 80 | MP0002876_abnormal_thyroid_physiology | 0.91586723 |
| 81 | MP0001486_abnormal_startle_reflex | 0.91281140 |
| 82 | MP0006036_abnormal_mitochondrial_physio | 0.89031005 |
| 83 | MP0003122_maternal_imprinting | 0.88865868 |
| 84 | MP0009642_abnormal_blood_homeostasis | 0.88858050 |
| 85 | MP0006072_abnormal_retinal_apoptosis | 0.88567244 |
| 86 | MP0001756_abnormal_urination | 0.87466155 |
| 87 | MP0005408_hypopigmentation | 0.86788940 |
| 88 | MP0008469_abnormal_protein_level | 0.86072036 |
| 89 | MP0002078_abnormal_glucose_homeostasis | 0.84094816 |
| 90 | MP0004142_abnormal_muscle_tone | 0.81381856 |
| 91 | MP0009745_abnormal_behavioral_response | 0.80998509 |
| 92 | MP0008789_abnormal_olfactory_epithelium | 0.79400523 |
| 93 | MP0010386_abnormal_urinary_bladder | 0.79374721 |
| 94 | MP0001485_abnormal_pinna_reflex | 0.78817492 |
| 95 | MP0000026_abnormal_inner_ear | 0.75800373 |
| 96 | MP0006276_abnormal_autonomic_nervous | 0.75192992 |
| 97 | MP0005376_homeostasis/metabolism_phenot | 0.75112690 |
| 98 | MP0004130_abnormal_muscle_cell | 0.73329480 |
| 99 | MP0002557_abnormal_social/conspecific_i | 0.72962293 |
| 100 | MP0002971_abnormal_brown_adipose | 0.72724122 |
| 101 | MP0001529_abnormal_vocalization | 0.72613376 |
| 102 | MP0002734_abnormal_mechanical_nocicepti | 0.72174069 |
| 103 | MP0005535_abnormal_body_temperature | 0.71868958 |
| 104 | MP0005334_abnormal_fat_pad | 0.71767728 |
| 105 | MP0009765_abnormal_xenobiotic_induced | 0.71383336 |
| 106 | MP0004885_abnormal_endolymph | 0.70122792 |
| 107 | MP0008775_abnormal_heart_ventricle | 0.69489354 |
| 108 | MP0004782_abnormal_surfactant_physiolog | 0.68403199 |
| 109 | MP0000749_muscle_degeneration | 0.68329830 |
| 110 | MP0002064_seizures | 0.68327893 |
| 111 | MP0001919_abnormal_reproductive_system | 0.68024029 |
| 112 | MP0001661_extended_life_span | 0.67127799 |
| 113 | MP0000631_abnormal_neuroendocrine_gland | 0.66170913 |
| 114 | MP0002572_abnormal_emotion/affect_behav | 0.64129643 |
| 115 | MP0002653_abnormal_ependyma_morphology | 0.63799721 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.63719851 |
| 117 | MP0000003_abnormal_adipose_tissue | 0.63697404 |
| 118 | MP0000015_abnormal_ear_pigmentation | 0.63167548 |
| 119 | MP0000747_muscle_weakness | 0.62727015 |
| 120 | MP0003690_abnormal_glial_cell | 0.62567009 |
| 121 | MP0005195_abnormal_posterior_eye | 0.62525540 |
| 122 | MP0000639_abnormal_adrenal_gland | 0.61705350 |
| 123 | MP0004043_abnormal_pH_regulation | 0.61300323 |
| 124 | MP0005448_abnormal_energy_balance | 0.59166921 |
| 125 | MP0002837_dystrophic_cardiac_calcinosis | 0.58808398 |
| 126 | MP0002928_abnormal_bile_duct | 0.58222796 |
| 127 | MP0009053_abnormal_anal_canal | 0.57323994 |
| 128 | MP0005266_abnormal_metabolism | 0.54456139 |
| 129 | MP0003638_abnormal_response/metabolism_ | 0.53962159 |
| 130 | MP0003724_increased_susceptibility_to | 0.52976082 |
| 131 | MP0003329_amyloid_beta_deposits | 0.51579648 |
| 132 | MP0005666_abnormal_adipose_tissue | 0.47652355 |
| 133 | MP0005395_other_phenotype | 0.47320957 |
| 134 | MP0003953_abnormal_hormone_level | 0.47204875 |
| 135 | MP0006035_abnormal_mitochondrial_morpho | 0.46272226 |
| 136 | MP0005464_abnormal_platelet_physiology | 0.45667457 |
| 137 | MP0000230_abnormal_systemic_arterial | 0.44921400 |
| 138 | MP0003075_altered_response_to | 0.43988174 |
| 139 | MP0008872_abnormal_physiological_respon | 0.40751634 |
| 140 | MP0002168_other_aberrant_phenotype | 0.40562272 |
| 141 | MP0008874_decreased_physiological_sensi | 0.39961475 |
| 142 | MP0001765_abnormal_ion_homeostasis | 0.38485643 |
| 143 | MP0009115_abnormal_fat_cell | 0.38356276 |
| 144 | MP0005167_abnormal_blood-brain_barrier | 0.37723901 |
| 145 | MP0005166_decreased_susceptibility_to | 0.37417153 |
| 146 | MP0009384_cardiac_valve_regurgitation | 0.37171727 |
| 147 | MP0002822_catalepsy | 0.36694902 |
| 148 | MP0008873_increased_physiological_sensi | 0.36359022 |
| 149 | MP0005248_abnormal_Harderian_gland | 0.34920963 |
| 150 | MP0000249_abnormal_blood_vessel | 0.34568693 |
| 151 | MP0005058_abnormal_lysosome_morphology | 0.34471788 |
| 152 | MP0002295_abnormal_pulmonary_circulatio | 0.34389298 |
| 153 | MP0003718_maternal_effect | 0.32686637 |
| 154 | MP0002796_impaired_skin_barrier | 0.32674042 |
| 155 | MP0009672_abnormal_birth_weight | 0.32265546 |
| 156 | MP0001944_abnormal_pancreas_morphology | 0.32090481 |
| 157 | MP0002135_abnormal_kidney_morphology | 0.30503839 |
| 158 | MP0003436_decreased_susceptibility_to | 0.29953583 |
| 159 | MP0002970_abnormal_white_adipose | 0.29943812 |
| 160 | MP0004883_abnormal_blood_vessel | 0.29709700 |
| 161 | MP0003959_abnormal_lean_body | 0.29273057 |
| 162 | MP0001845_abnormal_inflammatory_respons | 0.29226022 |
| 163 | MP0002060_abnormal_skin_morphology | 0.28590576 |
| 164 | MP0003300_gastrointestinal_ulcer | 0.28407490 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.27733042 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.08020435 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.95082298 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.34372017 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.07818468 |
| 6 | Xanthomatosis (HP:0000991) | 6.01156104 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.98526494 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.30563800 |
| 9 | Testicular atrophy (HP:0000029) | 4.94425913 |
| 10 | Complement deficiency (HP:0004431) | 4.91455202 |
| 11 | Increased hepatocellular lipid droplets (HP:0006565) | 4.90085591 |
| 12 | Lipid accumulation in hepatocytes (HP:0006561) | 4.71556715 |
| 13 | Hyperammonemia (HP:0001987) | 4.62306855 |
| 14 | Rib fusion (HP:0000902) | 4.56412392 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.54183251 |
| 16 | Joint hemorrhage (HP:0005261) | 4.51980453 |
| 17 | Ketosis (HP:0001946) | 4.49896528 |
| 18 | Hyperglycinemia (HP:0002154) | 4.44667101 |
| 19 | Mesangial abnormality (HP:0001966) | 4.42330535 |
| 20 | Renal Fanconi syndrome (HP:0001994) | 4.39751156 |
| 21 | Attenuation of retinal blood vessels (HP:0007843) | 4.38404016 |
| 22 | Hyperglycinuria (HP:0003108) | 4.29958666 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.28351374 |
| 24 | Hypoglycemic coma (HP:0001325) | 4.21720061 |
| 25 | Epidermoid cyst (HP:0200040) | 4.19184856 |
| 26 | Dyschromatopsia (HP:0007641) | 4.18931739 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 4.17121652 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.15017310 |
| 29 | Abnormality of glycine metabolism (HP:0010895) | 4.14314672 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.14314672 |
| 31 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.12040932 |
| 32 | Fat malabsorption (HP:0002630) | 4.08112306 |
| 33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.06010483 |
| 34 | Abnormality of methionine metabolism (HP:0010901) | 4.03575283 |
| 35 | Hypoalphalipoproteinemia (HP:0003233) | 4.02928967 |
| 36 | Popliteal pterygium (HP:0009756) | 3.97844579 |
| 37 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.79378459 |
| 38 | Congenital stationary night blindness (HP:0007642) | 3.70384134 |
| 39 | Abnormality of the intrinsic pathway (HP:0010989) | 3.68920851 |
| 40 | Increased intramyocellular lipid droplets (HP:0012240) | 3.63070361 |
| 41 | Decreased central vision (HP:0007663) | 3.61369943 |
| 42 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.58476515 |
| 43 | Conjugated hyperbilirubinemia (HP:0002908) | 3.52971299 |
| 44 | Abnormality of complement system (HP:0005339) | 3.52822259 |
| 45 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.52501566 |
| 46 | Ketoacidosis (HP:0001993) | 3.51131139 |
| 47 | Facial diplegia (HP:0001349) | 3.48295075 |
| 48 | Increased muscle lipid content (HP:0009058) | 3.41987984 |
| 49 | Hypercholesterolemia (HP:0003124) | 3.39235602 |
| 50 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.37302197 |
| 51 | Aplasia of the musculature (HP:0100854) | 3.35280686 |
| 52 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.35092088 |
| 53 | Hyperbilirubinemia (HP:0002904) | 3.31542618 |
| 54 | Rectovaginal fistula (HP:0000143) | 3.29440998 |
| 55 | Rectal fistula (HP:0100590) | 3.29440998 |
| 56 | Exertional dyspnea (HP:0002875) | 3.21772301 |
| 57 | Akinesia (HP:0002304) | 3.19845949 |
| 58 | Abnormality of nucleobase metabolism (HP:0010932) | 3.18271673 |
| 59 | Delayed CNS myelination (HP:0002188) | 3.14323459 |
| 60 | Fetal akinesia sequence (HP:0001989) | 3.10069918 |
| 61 | Vaginal fistula (HP:0004320) | 3.09437583 |
| 62 | Steatorrhea (HP:0002570) | 3.08307578 |
| 63 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.06333647 |
| 64 | Choroideremia (HP:0001139) | 3.06112317 |
| 65 | Gout (HP:0001997) | 3.02305819 |
| 66 | Mitochondrial inheritance (HP:0001427) | 3.01472356 |
| 67 | Abnormality of purine metabolism (HP:0004352) | 3.01156726 |
| 68 | Hepatocellular carcinoma (HP:0001402) | 3.01053361 |
| 69 | Abnormality of serum amino acid levels (HP:0003112) | 3.00430785 |
| 70 | Metabolic acidosis (HP:0001942) | 2.93900842 |
| 71 | Amniotic constriction ring (HP:0009775) | 2.89012444 |
| 72 | Abnormality of placental membranes (HP:0011409) | 2.89012444 |
| 73 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.83343964 |
| 74 | Dicarboxylic aciduria (HP:0003215) | 2.83343964 |
| 75 | Chorioretinal atrophy (HP:0000533) | 2.83126837 |
| 76 | Coronal craniosynostosis (HP:0004440) | 2.79202772 |
| 77 | Myocardial infarction (HP:0001658) | 2.78361494 |
| 78 | Myotonia (HP:0002486) | 2.77241293 |
| 79 | Hypoalbuminemia (HP:0003073) | 2.76363204 |
| 80 | Abnormal albumin level (HP:0012116) | 2.76363204 |
| 81 | Hypoglycemic seizures (HP:0002173) | 2.75121271 |
| 82 | Abnormality of renal resorption (HP:0011038) | 2.74787371 |
| 83 | Intestinal fistula (HP:0100819) | 2.71926821 |
| 84 | Lethargy (HP:0001254) | 2.70496011 |
| 85 | Vascular calcification (HP:0004934) | 2.66960316 |
| 86 | Spontaneous abortion (HP:0005268) | 2.66484525 |
| 87 | Skin nodule (HP:0200036) | 2.64375439 |
| 88 | Systemic lupus erythematosus (HP:0002725) | 2.63810298 |
| 89 | Increased CSF lactate (HP:0002490) | 2.61500344 |
| 90 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.57711515 |
| 91 | Hepatocellular necrosis (HP:0001404) | 2.57709061 |
| 92 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.55053884 |
| 93 | Generalized aminoaciduria (HP:0002909) | 2.51692009 |
| 94 | Hypochromic microcytic anemia (HP:0004840) | 2.49412592 |
| 95 | Delayed epiphyseal ossification (HP:0002663) | 2.45780065 |
| 96 | Malnutrition (HP:0004395) | 2.44806376 |
| 97 | Cerebral edema (HP:0002181) | 2.42939498 |
| 98 | Mitral stenosis (HP:0001718) | 2.40098441 |
| 99 | Cardiovascular calcification (HP:0011915) | 2.39166396 |
| 100 | Abnormal gallbladder morphology (HP:0012437) | 2.38971278 |
| 101 | Hepatic necrosis (HP:0002605) | 2.38360838 |
| 102 | Amyloidosis (HP:0011034) | 2.37925076 |
| 103 | Abnormal urine phosphate concentration (HP:0012599) | 2.36792131 |
| 104 | Acanthocytosis (HP:0001927) | 2.36706867 |
| 105 | Respiratory difficulties (HP:0002880) | 2.36355205 |
| 106 | Irritability (HP:0000737) | 2.35185385 |
| 107 | Neonatal onset (HP:0003623) | 2.34356237 |
| 108 | Spastic diplegia (HP:0001264) | 2.33870502 |
| 109 | Facial hemangioma (HP:0000329) | 2.32616943 |
| 110 | Type 2 muscle fiber atrophy (HP:0003554) | 2.30910568 |
| 111 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.30666221 |
| 112 | Cholelithiasis (HP:0001081) | 2.30602555 |
| 113 | Glomerulonephritis (HP:0000099) | 2.29855567 |
| 114 | Late onset (HP:0003584) | 2.27795221 |
| 115 | Annular pancreas (HP:0001734) | 2.26981629 |
| 116 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.26536137 |
| 117 | Esophageal varix (HP:0002040) | 2.26246856 |
| 118 | Poikiloderma (HP:0001029) | 2.24820754 |
| 119 | Absent thumb (HP:0009777) | 2.24605964 |
| 120 | Cholecystitis (HP:0001082) | 2.24217988 |
| 121 | Abnormal gallbladder physiology (HP:0012438) | 2.24217988 |
| 122 | Molar tooth sign on MRI (HP:0002419) | 2.23263931 |
| 123 | Abnormality of midbrain morphology (HP:0002418) | 2.23263931 |
| 124 | Sensorimotor neuropathy (HP:0007141) | 2.23160584 |
| 125 | Vomiting (HP:0002013) | 2.22850266 |
| 126 | Pancreatitis (HP:0001733) | 2.22777423 |
| 127 | Enlarged kidneys (HP:0000105) | 2.22775418 |
| 128 | Alkalosis (HP:0001948) | 2.22701302 |
| 129 | Hyperphosphaturia (HP:0003109) | 2.19632537 |
| 130 | Pancreatic fibrosis (HP:0100732) | 2.15714113 |
| 131 | Acute encephalopathy (HP:0006846) | 2.13932030 |
| 132 | Thin bony cortex (HP:0002753) | 2.12021563 |
| 133 | Hydroxyprolinuria (HP:0003080) | 2.11935149 |
| 134 | Abnormality of proline metabolism (HP:0010907) | 2.11935149 |
| 135 | True hermaphroditism (HP:0010459) | 2.11921795 |
| 136 | Proximal tubulopathy (HP:0000114) | 2.10792233 |
| 137 | Acute necrotizing encephalopathy (HP:0006965) | 2.08195850 |
| 138 | Turricephaly (HP:0000262) | 2.07882353 |
| 139 | Nephronophthisis (HP:0000090) | 2.06431742 |
| 140 | Neonatal respiratory distress (HP:0002643) | 2.06024375 |
| 141 | Rickets (HP:0002748) | 2.05144529 |
| 142 | Brushfield spots (HP:0001088) | 2.04690386 |
| 143 | Menorrhagia (HP:0000132) | 2.04535884 |
| 144 | Increased purine levels (HP:0004368) | 2.04478601 |
| 145 | Hyperuricemia (HP:0002149) | 2.04478601 |
| 146 | Renal tubular dysfunction (HP:0000124) | 2.02958632 |
| 147 | Optic disc pallor (HP:0000543) | 2.01641830 |
| 148 | Pancreatic cysts (HP:0001737) | 2.00204362 |
| 149 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.00052225 |
| 150 | Abnormality of the gallbladder (HP:0005264) | 1.98763539 |
| 151 | Patellar aplasia (HP:0006443) | 1.98556911 |
| 152 | Abnormal cartilage morphology (HP:0002763) | 1.97322519 |
| 153 | Opisthotonus (HP:0002179) | 1.97290801 |
| 154 | Polydipsia (HP:0001959) | 1.96881123 |
| 155 | Abnormal drinking behavior (HP:0030082) | 1.96881123 |
| 156 | Ulnar bowing (HP:0003031) | 1.96373261 |
| 157 | Abnormality of urine glucose concentration (HP:0011016) | 1.96197751 |
| 158 | Glycosuria (HP:0003076) | 1.96197751 |
| 159 | Abnormal biliary tract physiology (HP:0012439) | 1.95472493 |
| 160 | Bile duct proliferation (HP:0001408) | 1.95472493 |
| 161 | Muscle fiber atrophy (HP:0100295) | 1.94720829 |
| 162 | Atrioventricular block (HP:0001678) | 1.93943870 |
| 163 | Pendular nystagmus (HP:0012043) | 1.93657417 |
| 164 | Renal cortical cysts (HP:0000803) | 1.93335656 |
| 165 | Hemorrhage of the eye (HP:0011885) | 1.93147271 |
| 166 | Gingival bleeding (HP:0000225) | 1.93079492 |
| 167 | Widely patent fontanelles and sutures (HP:0004492) | 1.92544408 |
| 168 | Symptomatic seizures (HP:0011145) | 1.91860259 |
| 169 | Abnormal epiphyseal ossification (HP:0010656) | 1.91148417 |
| 170 | Thrombophlebitis (HP:0004418) | 1.90898460 |
| 171 | Squamous cell carcinoma (HP:0002860) | 1.89952458 |
| 172 | Hyperglycemia (HP:0003074) | 1.88822843 |
| 173 | Zonular cataract (HP:0010920) | 1.87560845 |
| 174 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.86039428 |
| 175 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.85816579 |
| 176 | Hypophosphatemic rickets (HP:0004912) | 1.85711040 |
| 177 | Elevated hepatic transaminases (HP:0002910) | 1.85420670 |
| 178 | Anteriorly placed anus (HP:0001545) | 1.82566287 |
| 179 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.82428267 |
| 180 | Tachypnea (HP:0002789) | 1.82269191 |
| 181 | Epiphyseal stippling (HP:0010655) | 1.80079221 |
| 182 | Methylmalonic aciduria (HP:0012120) | 1.79579902 |
| 183 | Medial flaring of the eyebrow (HP:0010747) | 1.78899680 |
| 184 | Diminished movement (HP:0002374) | 1.78528566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.15859932 |
| 2 | SIK1 | 4.33769054 |
| 3 | ERN1 | 4.13735609 |
| 4 | FGFR4 | 4.10136068 |
| 5 | MUSK | 3.72140511 |
| 6 | INSRR | 3.70346659 |
| 7 | ZAK | 2.93844661 |
| 8 | TLK1 | 2.75350776 |
| 9 | TAOK3 | 2.66015815 |
| 10 | ADRBK2 | 2.54951009 |
| 11 | MST1R | 2.47100325 |
| 12 | ERBB4 | 2.24038446 |
| 13 | MAP4K2 | 2.09772534 |
| 14 | ACVR1B | 2.06473083 |
| 15 | STK16 | 1.99479733 |
| 16 | FLT3 | 1.95673825 |
| 17 | MAP2K4 | 1.91548648 |
| 18 | PKN2 | 1.89489304 |
| 19 | BMPR1B | 1.87699629 |
| 20 | FRK | 1.85475274 |
| 21 | TRIB3 | 1.81404922 |
| 22 | STK39 | 1.78320572 |
| 23 | OBSCN | 1.74394679 |
| 24 | PIK3CG | 1.73428026 |
| 25 | MAPK11 | 1.68154342 |
| 26 | STK38L | 1.65447195 |
| 27 | PHKG2 | 1.57216794 |
| 28 | PHKG1 | 1.57216794 |
| 29 | DAPK2 | 1.54128670 |
| 30 | NUAK1 | 1.49640194 |
| 31 | PDK2 | 1.47983254 |
| 32 | ADRBK1 | 1.47756987 |
| 33 | PTK6 | 1.43990371 |
| 34 | TYK2 | 1.43607706 |
| 35 | VRK2 | 1.40872792 |
| 36 | TIE1 | 1.33236869 |
| 37 | MAPK15 | 1.33105506 |
| 38 | LATS1 | 1.29491595 |
| 39 | NEK9 | 1.28341101 |
| 40 | ABL2 | 1.27433622 |
| 41 | PRKAA2 | 1.17450792 |
| 42 | VRK1 | 1.14227384 |
| 43 | FGFR2 | 1.13083737 |
| 44 | PINK1 | 1.11298429 |
| 45 | MAP2K3 | 1.10446422 |
| 46 | KDR | 1.08111759 |
| 47 | JAK2 | 1.07788129 |
| 48 | EPHA4 | 1.06419103 |
| 49 | MAP3K7 | 1.04397666 |
| 50 | EPHA3 | 1.04051166 |
| 51 | CCNB1 | 1.01388266 |
| 52 | MET | 1.01386690 |
| 53 | MAP3K3 | 1.01164293 |
| 54 | TRIM28 | 0.99270854 |
| 55 | CAMK1D | 0.97961292 |
| 56 | TGFBR2 | 0.97063853 |
| 57 | JAK1 | 0.96034023 |
| 58 | DYRK2 | 0.94454818 |
| 59 | PIM2 | 0.92257802 |
| 60 | TBK1 | 0.90572378 |
| 61 | IRAK3 | 0.90104206 |
| 62 | AKT3 | 0.88345933 |
| 63 | PAK3 | 0.86241632 |
| 64 | EPHB1 | 0.86205399 |
| 65 | MAP3K14 | 0.86043079 |
| 66 | GRK6 | 0.85977599 |
| 67 | MAP3K4 | 0.84354667 |
| 68 | RIPK1 | 0.84291979 |
| 69 | SGK3 | 0.84159075 |
| 70 | CSNK1G3 | 0.82565747 |
| 71 | GSK3A | 0.82091395 |
| 72 | MAPK4 | 0.81930706 |
| 73 | MYLK | 0.79265827 |
| 74 | PRKCZ | 0.75444013 |
| 75 | ERBB2 | 0.74831992 |
| 76 | MAP2K6 | 0.74129533 |
| 77 | NME1 | 0.73840770 |
| 78 | WNK4 | 0.73588904 |
| 79 | WNK3 | 0.73566772 |
| 80 | RPS6KA5 | 0.73471840 |
| 81 | MAPK13 | 0.73147538 |
| 82 | SGK2 | 0.71546618 |
| 83 | GRK5 | 0.71023433 |
| 84 | PRKD3 | 0.70207547 |
| 85 | PRKACG | 0.70184377 |
| 86 | MAP2K7 | 0.69381260 |
| 87 | CSNK1G2 | 0.69299013 |
| 88 | MAPK12 | 0.68338125 |
| 89 | GRK1 | 0.68017972 |
| 90 | MST4 | 0.67649336 |
| 91 | CSK | 0.66664579 |
| 92 | BRSK2 | 0.66487390 |
| 93 | PTK2 | 0.65543806 |
| 94 | PRKAA1 | 0.65209663 |
| 95 | PRKCE | 0.64207390 |
| 96 | CSNK1A1L | 0.63999039 |
| 97 | TGFBR1 | 0.63712913 |
| 98 | PRKACA | 0.63237341 |
| 99 | CAMK2G | 0.61585717 |
| 100 | DYRK1B | 0.60519212 |
| 101 | SGK223 | 0.60456138 |
| 102 | SGK494 | 0.60456138 |
| 103 | MAP3K11 | 0.60087496 |
| 104 | MAPKAPK3 | 0.59321866 |
| 105 | BLK | 0.58154598 |
| 106 | IKBKE | 0.57973665 |
| 107 | PDK3 | 0.57669423 |
| 108 | PDK4 | 0.57669423 |
| 109 | CDK6 | 0.54512128 |
| 110 | MAP2K1 | 0.54438936 |
| 111 | WNK1 | 0.54237776 |
| 112 | CAMK1 | 0.53331302 |
| 113 | MAP3K10 | 0.52536701 |
| 114 | MAP2K2 | 0.51700727 |
| 115 | FGFR3 | 0.51622170 |
| 116 | PDPK1 | 0.51140199 |
| 117 | PKN1 | 0.48375023 |
| 118 | MAPKAPK5 | 0.48078144 |
| 119 | MAP3K2 | 0.48038010 |
| 120 | DYRK3 | 0.46743160 |
| 121 | PRKCQ | 0.45648506 |
| 122 | DAPK3 | 0.45584853 |
| 123 | PRKD1 | 0.45062645 |
| 124 | MAPK7 | 0.44181121 |
| 125 | PLK3 | 0.43777986 |
| 126 | CAMK2D | 0.43340618 |
| 127 | CSNK1G1 | 0.43160514 |
| 128 | CAMK2A | 0.43137896 |
| 129 | STK11 | 0.42842990 |
| 130 | IGF1R | 0.41725427 |
| 131 | PLK1 | 0.41506655 |
| 132 | IRAK1 | 0.41471751 |
| 133 | PRKG1 | 0.41046050 |
| 134 | RET | 0.40782760 |
| 135 | CASK | 0.40227260 |
| 136 | BMX | 0.40181305 |
| 137 | PAK1 | 0.39819726 |
| 138 | PIK3CA | 0.38431346 |
| 139 | CSF1R | 0.37558372 |
| 140 | PRKCH | 0.36334670 |
| 141 | CSNK1D | 0.36084715 |
| 142 | CSNK1A1 | 0.34402122 |
| 143 | PLK2 | 0.33463392 |
| 144 | PTK2B | 0.33348545 |
| 145 | MAP3K1 | 0.33180146 |
| 146 | ROCK1 | 0.32539992 |
| 147 | MAP3K5 | 0.32186864 |
| 148 | CAMK1G | 0.31325265 |
| 149 | PRKCI | 0.31284129 |
| 150 | NTRK2 | 0.30461621 |
| 151 | TAOK2 | 0.30349323 |
| 152 | PDGFRA | 0.29630510 |
| 153 | EPHB2 | 0.29100259 |
| 154 | CAMK4 | 0.28529248 |
| 155 | BUB1 | 0.28342468 |
| 156 | ZAP70 | 0.28302827 |
| 157 | MARK1 | 0.27691114 |
| 158 | AURKA | 0.27606536 |
| 159 | PDK1 | 0.26116992 |
| 160 | PRKCA | 0.24835029 |
| 161 | OXSR1 | 0.24696362 |
| 162 | EGFR | 0.23405450 |
| 163 | FER | 0.22919764 |
| 164 | PRKCG | 0.22705142 |
| 165 | CDK4 | 0.21993564 |
| 166 | MAP3K13 | 0.21581685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.32861600 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.47067315 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.37367822 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.16478132 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.90211140 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71239217 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.64840247 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62782732 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.58133685 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.57309456 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.54839755 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.47603988 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.31493769 |
| 14 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.31144821 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.24059842 |
| 16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.18451998 |
| 17 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14530206 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.13080639 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 2.11868105 |
| 20 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.91200723 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91141548 |
| 22 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.89055990 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.88492417 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87371123 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.85499272 |
| 26 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.82820136 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.76457985 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73632025 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.72999481 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.69948045 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.66202387 |
| 32 | Parkinsons disease_Homo sapiens_hsa05012 | 1.65244696 |
| 33 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.64143375 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.62568348 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62003912 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.57197210 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.55973526 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55955993 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54545975 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50876005 |
| 41 | Bile secretion_Homo sapiens_hsa04976 | 1.50693136 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46174661 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42446828 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39194061 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34690468 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32969966 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.25539336 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.23607381 |
| 49 | Huntingtons disease_Homo sapiens_hsa05016 | 1.23478990 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.22908983 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.21897162 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.21656181 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.20566617 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 1.18398747 |
| 55 | RNA polymerase_Homo sapiens_hsa03020 | 1.17004450 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16869604 |
| 57 | Alzheimers disease_Homo sapiens_hsa05010 | 1.16572020 |
| 58 | Phototransduction_Homo sapiens_hsa04744 | 1.15214751 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14622835 |
| 60 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.14408894 |
| 61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.12643894 |
| 62 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.10491947 |
| 63 | Circadian rhythm_Homo sapiens_hsa04710 | 1.07481980 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05745016 |
| 65 | Nicotine addiction_Homo sapiens_hsa05033 | 1.05007989 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.03622788 |
| 67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01496315 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00772313 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95976409 |
| 70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.94887785 |
| 71 | Taste transduction_Homo sapiens_hsa04742 | 0.93401584 |
| 72 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91363990 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87984650 |
| 74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84353835 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.80143119 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.79052203 |
| 77 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75205246 |
| 78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71556458 |
| 79 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.69939475 |
| 80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.69226897 |
| 81 | * Glutathione metabolism_Homo sapiens_hsa00480 | 0.67911245 |
| 82 | Cocaine addiction_Homo sapiens_hsa05030 | 0.62056055 |
| 83 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.59848994 |
| 84 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.59808739 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59667529 |
| 86 | Basal transcription factors_Homo sapiens_hsa03022 | 0.59221425 |
| 87 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58406680 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57806212 |
| 89 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.56526249 |
| 90 | Insulin secretion_Homo sapiens_hsa04911 | 0.56345226 |
| 91 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55350879 |
| 92 | Protein export_Homo sapiens_hsa03060 | 0.55262111 |
| 93 | Ribosome_Homo sapiens_hsa03010 | 0.53438224 |
| 94 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.52025398 |
| 95 | Purine metabolism_Homo sapiens_hsa00230 | 0.51470191 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47553927 |
| 97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44504710 |
| 98 | GABAergic synapse_Homo sapiens_hsa04727 | 0.40010860 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39120812 |
| 100 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.37854585 |
| 101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33073510 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31519859 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.28366568 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27003540 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.25900888 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24474440 |
| 107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21996239 |
| 108 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14864040 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13405380 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10587731 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04601277 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.03038610 |
| 113 | Lysosome_Homo sapiens_hsa04142 | -0.2219313 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2160837 |
| 115 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2114038 |
| 116 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1745086 |
| 117 | Hepatitis C_Homo sapiens_hsa05160 | -0.1722143 |
| 118 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1657159 |
| 119 | Mineral absorption_Homo sapiens_hsa04978 | -0.1619009 |
| 120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1598490 |
| 121 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1489002 |
| 122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1436983 |
| 123 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1118507 |
| 124 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1007146 |
| 125 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0941864 |
| 126 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0927640 |
| 127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0875219 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0840451 |
| 129 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0779682 |
| 130 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0775377 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0631023 |
| 132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0392243 |

